← 27 Aug 2026 · Short-term Top 10 — Health Care
Short-term Top 10 — Health Care — what changed on 28 Aug 2026
A dated record of one session: what entered or left, what moved inside the ten and by how much, who is closest to the boundary, and how the list did against its benchmark. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100.
The short-term score is a published weighted sum of percentile ranks, rebalanced every Monday. A list is a published formula and its output, not a recommendation. Method version 3.
Get this list's changes every morning
One short email a day: who entered, who left, and the reason — with the score moves behind it.
Informational only — not financial advice. One email a day, unsubscribe in one click.
Membership
No company entered or left on 28 Aug 2026. The next scheduled change is at this list's next rebalance.
Inside the ten
Against the previous session, 27 Aug 2026.
| Company | Rank | Score | Pillar that moved most |
|---|---|---|---|
| HINGE HEALTH INC CLASS A (HNGE) | 2 +1 | 71.3 +1.4 | Setup 36th → 61st |
| KINIKSA PHARMACEUTICALS INTERNATIO (KNSA) | 8 +6 | 68.1 +2.0 | Catalysts 62nd → 68th |
| GLAUKOS CORP (GKOS) | 9 −3 | 68.0 −0.8 | Catalysts 78th → 61st |
| Moderna (MRNA) | 13 | 66.0 −0.6 | Trend 84th → 79th |
| Revolution Medicines (RVMD) | 20 −11 | 64.3 −4.2 | Trend 86th → 59th |
| Merck & Co. (MRK) | 38 −28 | 61.4 −6.6 | Catalysts 90th → 54th |
| IMMUNOME INC (IMNM) | 46 −39 | 60.5 −8.3 | Catalysts 92nd → 62nd |
| DEFINIUM THERAPEUTICS INC (DFTX) | 82 −59 | 57.2 −5.9 | Trend 70th → 38th |
| NUVATION BIO INC CLASS A (NUVB) | 121 −77 | 52.5 −8.1 | Trend 70th → 62nd |
| ZENAS BIOPHARMA INC (ZBIO) | 135 −84 | 50.6 −9.3 | Volume and participation 51st → 31st |
At the edge
Knocking
- Corcept Therapeutics (CORT) scores 25.2 above the lowest member — the sector cap, not the score, is what is keeping it out
- RAPPORT THERAPEUTICS INC (RAPP) scores 20.6 above the lowest member — the sector cap, not the score, is what is keeping it out
Closest to the exit
- DEFINIUM THERAPEUTICS INC (DFTX) 8.4 below the score at rank 15, where the hold band ends
- NUVATION BIO INC CLASS A (NUVB) 13.1 below the score at rank 15, where the hold band ends
- ZENAS BIOPHARMA INC (ZBIO) 15.0 below the score at rank 15, where the hold band ends
Ranked against 238 eligible Health Care companies on this session. A company at the edge is a company near a boundary, not a prediction that it will cross one.
Against the benchmark
SPY is the S&P 500 ETF — the US large-cap market average.
−3.9% since the previous session (2026-08-27), against −0.2% for SPY — 3.7 points behind the benchmark. Tracked since 2026-08-18.
−2.0% since 2026-08-18, against +0.2% for SPY — 2.2 points behind the benchmark. Tracked since 2026-08-18.
Both curves are total return through 28 Aug 2026: a distribution buys more of the company that paid it, on the benchmark as much as on the list.
More
Informational only — NOT financial advice.